Pros and cons of inhibiting cholesteryl ester transfer protein.
about
Effect of Synthetic Truncated Apolipoprotein C-I Peptide on Plasma Lipoprotein Cholesterol in Nonhuman PrimatesSelective evaluation of high density lipoprotein from mouse small intestine by an in situ perfusion technique.Novel agents for managing dyslipidaemia.c.*84G>A Mutation in CETP Is Associated with Coronary Artery Disease in South IndiansHigh density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease.Much lower prevalence of coronary calcium detected by electron-beam computed tomography among men aged 40-49 in Japan than in the US, despite a less favorable profile of major risk factors.Is high HDL cholesterol always good?Disease-associated marked hyperalphalipoproteinemia.An integrated approach for the mechanisms responsible for atherosclerotic plaque regressionApolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice.A "natural experiment" in cardiovascular epidemiology in the early 21st century.Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader assay.Expression of simian CETP in normolipidemic Fisher rats has a profound effect on large sized apoE-containing HDL.Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice.Cholesteryl ester transfer protein expression is down-regulated in hyperinsulinemic transgenic mice.Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS).
P2860
Q24805786-82EEDCF1-E98C-4297-9D3F-16285463395CQ30576734-37A692C4-146C-4A70-BC8D-986A935C4DC6Q34481800-EBCE6C47-3CBC-4D61-86FF-A617F079D715Q36170750-AFF02309-1971-474D-85B2-CF0E05533E92Q36766976-56BDFAE1-4B37-4C6D-8513-39CF5BAA9EBCQ36854149-D27F60F4-05C5-4754-AF92-B97B0E955B96Q37351659-C3C13EB5-3606-4421-8A87-527B3DBA5A99Q37434051-3D415F3A-6B8B-48AD-B3F1-DB9B4C389657Q38963714-4AC82F83-7A2D-4FDA-A693-34ACD0141E1BQ41825540-0AAA1AD3-605F-40DC-9AE5-4E26FE6F82D6Q43015074-74E9DCD0-B00D-4804-AEE6-4ECFCDB408F4Q44046083-CCB8F410-8BF1-43E7-BB83-09A1248714D0Q44231232-E78D47E7-8DC3-4FA8-80B6-A05DC30F5B87Q44272158-B166C085-7F70-462C-A287-FB357AAE637CQ44516295-B004130F-2715-480D-B36F-48D01F0AD2DDQ44776753-52257B7E-C427-4BF7-9E31-7B94CAA7C5ED
P2860
Pros and cons of inhibiting cholesteryl ester transfer protein.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pros and cons of inhibiting cholesteryl ester transfer protein.
@ast
Pros and cons of inhibiting cholesteryl ester transfer protein.
@en
Pros and cons of inhibiting cholesteryl ester transfer protein.
@nl
type
label
Pros and cons of inhibiting cholesteryl ester transfer protein.
@ast
Pros and cons of inhibiting cholesteryl ester transfer protein.
@en
Pros and cons of inhibiting cholesteryl ester transfer protein.
@nl
prefLabel
Pros and cons of inhibiting cholesteryl ester transfer protein.
@ast
Pros and cons of inhibiting cholesteryl ester transfer protein.
@en
Pros and cons of inhibiting cholesteryl ester transfer protein.
@nl
P2093
P1476
Pros and cons of inhibiting cholesteryl ester transfer protein.
@en
P2093
Matsuzawa Y
Yamashita S
P304
P356
10.1097/00041433-200012000-00004
P577
2000-12-01T00:00:00Z